JOIN OUR NETWORK
REALITY
Real-world data has the promise of advancing precision medicine. Current efforts, although important, do not collect the quality of data needed to fill a gap between the mining of electronic medical records and traditional interventional clinical trials. Physicians and oncologists need new revenue streams to offset the time and costs required to collect quality data.
SOLUTION
By providing a novel data collection platform, Taproot Health can collect the missing data needed to advance precision medicine and, when licensed for research, provide revenue sharing to clinics based on the quality and quantity of data they provide to Taproot Health.
ROOT is a national observational clinical trial enabling patients and clinicians to identify, collect, and share the highest quality cancer data in an efficient manner. Clinics report information on behalf of patients in a format that provides the greatest research benefit. Oncologists and patients can help identify new biomarkers and treatments, and eventually find specific patients to participate in new diagnostic testing or therapeutic trials. We can collect treatment response and behavioral data directly from patients through patient self-reporting—enhancing ROOT data. Further, Taproot Health will continually streamline the data-collection process.
HELP BUILD A NATIONAL ONCOLOGY DATABASE THAT BENEFITS EVERYONE.
PATIENT CONSENT
Patients are asked to participate.This patient consent protects them and ensures that all data-sharing is compliant with modern privacy laws. Plus, patients can be contacted when new biomarker testing is available or when they qualify for research opportunities.
A SHARED EFFORT
Change happens when we all
work together.When it comes to curing cancer, the power is in the
numbers. Not one oncologist or clinic can do it alone. As an oncology community, we can build something stronger and more powerful than anything we could build as individuals.
A PARTNERSHIP MODEL
Clinics are treated as partners.Partner clinics can access data for cancer research. They can also share in any net revenue from licensing that data. There’s full transparency in data sharing—so researchers always know how data is being used.
A NOVEL CLINICAL
TRIAL AND DATABASE
Incomplete or inaccurate data
benefits no one.The right data must be collected in the right manner to be valuable. We provide tools and training for molecular classification, data entry and clinical flow—all to provide regulatory-grade data.
